Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-4-24
|
pubmed:abstractText |
A patient with Philadelphia (Ph) chromosome-positive chronic myelogenous leukemia (CML) who was treated with alpha-interferon (alpha-IFN) is reported. After the treatment, the number of Ph+ bone marrow (BM) cells decreased gradually and the intensity of the rearranged major breakpoint cluster region (M-BCR) gene became faint; however, a lymphoblastic crisis developed about 1 year later. At the time of the blast crisis, the rearranged M-BCR band was detected, indicating that the blast crisis clone was derived from CML cells. The patient was treated with a combination of vincristine, prednisolone, daunorubicin, and L-asparaginase, and a hematologic remission was obtained. During the remission status, no rearranged M-BCR fragment was detected by conventional Southern analysis. Thus, the hematologic and genetic alteration in this case appeared to be identical to Ph+ acute leukemia with M-BCR rearrangement. The current case therefore indicates that alpha-IFN can reduce the proportion of Ph+ cells, but is unable to prevent blast crisis. Furthermore, the quantitative reduction of the cell population with a Ph chromosome may have some effects in modifying the genetic manifestations and clinical features of Ph+ CML, e.g., the delay in the appearance of the blast crisis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Asparaginase,
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0165-4608
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
165-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1551082-Antigens, CD,
pubmed-meshheading:1551082-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1551082-Asparaginase,
pubmed-meshheading:1551082-Blast Crisis,
pubmed-meshheading:1551082-Bone Marrow,
pubmed-meshheading:1551082-Chromosome Aberrations,
pubmed-meshheading:1551082-Chromosome Banding,
pubmed-meshheading:1551082-Daunorubicin,
pubmed-meshheading:1551082-Gene Rearrangement,
pubmed-meshheading:1551082-Humans,
pubmed-meshheading:1551082-Interferon-alpha,
pubmed-meshheading:1551082-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:1551082-Male,
pubmed-meshheading:1551082-Middle Aged,
pubmed-meshheading:1551082-Prednisolone,
pubmed-meshheading:1551082-Remission Induction,
pubmed-meshheading:1551082-Vincristine
|
pubmed:year |
1992
|
pubmed:articleTitle |
Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.
|
pubmed:affiliation |
First Department of Internal Medicine, Tokyo Medical College, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|